Pricing:

Single User Licence
$4200
Multi User License Upto 5 Users
$6500
Enterprise License
$8400
Download Sample Add to Cart Buy Now

Don’t see what you are Looking For:

We can create a custom report for you, please fill the form below

Download Free Sample Now

Global Cardiovascular Surgery Devices And Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, and Perfusion Disposables

By Application;

Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, and Other Applications

By End Use;

Home and Ambulatory care, Hospitals, Diagnostic laboratories, and Research laboratories

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)

Report ID: Rn119185528 Published Date: May, 2025 Updated Date: June, 2025

Download Free Sample Now Request Customized Sample

Cardiovascular Surgery Devices And Equipment Market Overview

Cardiovascular Surgery Devices And Equipment Market (USD Million)

Cardiovascular Surgery Devices And Equipment Market was valued at USD 11,726.62 million in the year 2024. The size of this market is expected to increase to USD 16,945.60 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.4%.

Global Cardiovascular Surgery Devices And Equipment Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 5.4 %

Study Period	2025 - 2031
Base Year	2024
CAGR (%)	5.4 %
Market Size (2024)	USD 11,726.62 Million
Market Size (2031)	USD 16,945.60 Million
Market Concentration	Medium
Report Pages	384

11,726.62

2024

16,945.60

2031

Major Players

Abbott Laboratories
Boston Scientific Corporation
Cook Medical
C.R.Bard
Abiomed.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Cardiovascular Surgery Devices And Equipment Market

Fragmented - Highly competitive market without dominant players

The market for cardiovascular surgery devices and equipment is expanding steadily, driven by the increasing prevalence of heart-related disorders and the rising number of surgical interventions. Cardiovascular diseases remain a major health burden, prompting greater reliance on specialized surgical tools. Currently, over 55% of all cardiovascular procedures utilize advanced surgical devices, emphasizing their central role in modern cardiac care.

Innovation Driving Clinical Advancements
Technological progress is a key force shaping the market, with innovations such as robotic-assisted systems and real-time imaging tools enhancing the precision of cardiovascular surgeries. These innovations have significantly reduced surgical risks and improved patient recovery. nearly 40% of procedures incorporate robotic or image-guided technologies, which are contributing to better clinical outcomes and fewer complications.

Shift Toward Minimally Invasive Techniques
Minimally invasive cardiovascular surgeries are becoming increasingly preferred by both patients and healthcare providers. These techniques reduce pain, scarring, and hospitalization times, which explains their growing adoption. In fact, more than 50% of cardiac surgeries are now conducted using minimally invasive methods, which require advanced and specially designed surgical instruments.

Healthcare Investments Fueling Equipment Demand
Robust investment in healthcare infrastructure is another factor accelerating market growth. Both public and private entities are actively upgrading surgical facilities to support advanced cardiovascular care. Over 45% of cardiac centers are either expanding or modernizing their equipment, indicating a strong push toward high-precision, technology-enabled surgical environments.

Promising Growth Outlook
Looking ahead, the cardiovascular surgery devices market is poised for continued growth. This is supported by ongoing research, collaborative ventures, and increased awareness about cardiovascular health. More than 60% of medical technology companies are currently focusing their R&D efforts on cardiovascular innovations, highlighting the strong market potential and long-term opportunities in this segment.

Cardiovascular Surgery Devices And Equipment Market Recent Developments

In February 2023, Medtronic introduced its Evolut FX TAVR system in the U.S. to improve care for patients with severe aortic stenosis. The system offers enhanced precision and control during minimally invasive procedures, aligning with the growing demand for advanced cardiac interventions.
In June 2022, Boston Scientific finalized the acquisition of Baylis Medical Company, known for its advanced transseptal access solutions. This strategic move boosts Boston Scientific’s position in the structural heart and electrophysiology markets, enhancing its range of cardiovascular surgery tools.

Cardiovascular Surgery Devices And Equipment Market Segment Analysis

In this report, the Cardiovascular Surgery Devices And Equipment Market has been segmented by Product, Application, End Use, and Geography.

Cardiovascular Surgery Devices And Equipment Market, Segmentation by Product

The Cardiovascular Surgery Devices And Equipment Market has been segmented by Product into Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices and Perfusion Disposables.

Beating Heart Surgery Systems

Beating heart surgery systems play a vital role in cardiovascular surgeries by allowing the heart to continue beating during the procedure. These systems help reduce the need for heart-lung machines, which can result in shorter recovery times and fewer complications for patients. Beating heart surgery systems contribute to around 40% of the cardiovascular surgery devices and equipment market, with their demand growing as healthcare providers focus on improving surgical outcomes.

Cardiopulmonary Bypass Equipment

Cardiopulmonary bypass equipment is essential in heart surgeries, temporarily taking over the functions of the heart and lungs. This equipment is crucial for many complex cardiac procedures, ensuring continuous blood flow and oxygenation. With a market share of approximately 35%, cardiopulmonary bypass equipment is expected to grow steadily as the number of heart surgeries increases and innovations in device technology enhance performance.

Cardiac Ablation Devices

Cardiac ablation devices are used to treat irregular heart rhythms (arrhythmias) by destroying abnormal heart tissue. With the rising prevalence of arrhythmias and a shift toward minimally invasive procedures, cardiac ablation devices are seeing increased demand. These devices account for roughly 15% of the cardiovascular surgery devices market and are poised for significant growth as non-invasive treatments become more popular.

Perfusion Disposables

Perfusion disposables, including single-use items such as tubing, filters, and oxygenators, are vital for ensuring blood flow during cardiovascular surgeries. These disposable products are designed to maximize efficiency and patient safety during heart surgeries. Perfusion disposables currently account for about 10% of the market and are expected to see steady growth as surgical centers and hospitals continue to favor disposable, high-quality products for cardiac procedures.

Cardiovascular Surgery Devices And Equipment Market, Segmentation by Application

The Cardiovascular Surgery Devices And Equipment Market has been segmented by Application into Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure and Other Applications.

Congenital Heart Defects

Congenital heart defects (CHDs) are among the most common birth defects globally, affecting a significant portion of the population. Cardiovascular surgery devices are crucial in the treatment of CHDs, which often require complex and life-saving surgical interventions. This segment is projected to hold a substantial market share, accounting for approximately 25% of the cardiovascular surgery devices and equipment market, with growth driven by early detection and advanced surgical treatments.

Cardiac Arrhythmia

Cardiac arrhythmia refers to irregular heartbeats, which can lead to severe complications if untreated. Devices designed for treating arrhythmias, such as ablation catheters and pacemakers, are crucial in managing these conditions. The market share for arrhythmia treatment devices is estimated at 30%, driven by the increasing prevalence of arrhythmias and the growing adoption of minimally invasive procedures.

Coronary Heart Disease

Coronary heart disease (CHD) remains one of the leading causes of death worldwide, resulting from the buildup of plaque in the coronary arteries. Cardiovascular surgery devices, including coronary artery bypass grafts and stents, are key tools in managing CHD. This application segment commands a dominant share of the market, estimated at 35%, owing to the high demand for surgical intervention and the increasing prevalence of heart disease globally.

Congestive Heart Failure

Congestive heart failure (CHF) occurs when the heart is unable to pump blood efficiently, leading to fluid buildup and other complications. Devices used in managing CHF include ventricular assist devices (VADs) and heart pumps. The CHF market segment is growing steadily, accounting for approximately 10% of the cardiovascular surgery devices and equipment market, driven by the aging population and the increasing need for advanced heart failure treatments.

Cardiovascular Surgery Devices And Equipment Market, Segmentation by End Use

The Cardiovascular Surgery Devices And Equipment Market has been segmented by End Use into Home and Ambulatory care, Hospitals, Diagnostic laboratories and Research laboratories.

Home and Ambulatory Care

Home and ambulatory care are increasingly popular due to the growing demand for outpatient treatments and the shift toward more cost-effective healthcare solutions. Cardiovascular devices used in these settings are critical for home-based monitoring and outpatient procedures, ensuring patients receive continuous care without hospitalization. This segment is expected to grow significantly, accounting for approximately 20% of the cardiovascular surgery devices and equipment market, driven by the preference for home care and outpatient services.

Hospitals

Hospitals remain the largest end-use segment for cardiovascular surgery devices and equipment. They are equipped with advanced infrastructure for complex surgeries and critical care. The hospital segment holds the largest market share, accounting for nearly 50%, driven by the increasing number of cardiovascular surgeries and the adoption of cutting-edge technology in treatment procedures. Hospitals continue to be the primary source of demand for these devices.

Diagnostic Laboratories

Diagnostic laboratories are essential for diagnosing cardiovascular diseases and providing accurate assessments for patients. The devices used in diagnostic laboratories include imaging tools, testing equipment, and monitoring devices crucial for identifying heart conditions. This segment holds about 15% of the market, with steady growth anticipated as diagnostic tools become more advanced and the global demand for early heart disease detection increases.

Research Laboratories

Research laboratories play a key role in the development and innovation of new cardiovascular devices and treatments. These labs are at the forefront of clinical trials and the creation of next-generation medical technologies. The research laboratory segment accounts for about 15% of the global market, with a focus on advancing knowledge in cardiovascular health and improving treatment outcomes through innovation.

Cardiovascular Surgery Devices And Equipment Market, Segmentation by Geography

In this report, the Cardiovascular Surgery Devices And Equipment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Regions and Countries Analyzed in this Report

Legend

North America

Rest of North America

Europe

Rest of Europe

Asia Pacific

Rest of Asia Pacific

Middle East and Africa

Rest of Middle East and Africa

Latin America

Rest of Latin America

Rest of the World

Cardiovascular Surgery Devices And Equipment Market Share (%), by Geographical Region

North America

North America holds the largest share in the cardiovascular surgery devices and equipment market, driven by advanced healthcare infrastructure and a high prevalence of cardiovascular diseases. The region is expected to account for approximately 40% of the market due to strong demand from the U.S. for innovative surgical devices and procedures. Additionally, the rising aging population and continuous technological advancements further fuel growth in this region.

Europe

Europe is another major market for cardiovascular surgery devices, accounting for about 30% of the global market share. This growth is supported by the region’s well-established healthcare systems, high levels of healthcare spending, and a growing elderly population. Countries like Germany, France, and the UK are significant contributors to the demand for advanced cardiovascular surgical technologies.

Asia Pacific

The Asia Pacific region is seeing rapid growth in the cardiovascular surgery devices market, projected to grow at a compound annual growth rate (CAGR) of around 8%. The demand for cardiovascular devices in this region is driven by the rising prevalence of cardiovascular diseases, increasing disposable incomes, and greater access to healthcare facilities. The region holds about 15% of the global market share, with countries like China and India showing significant potential for market expansion.

Middle East and Africa

The Middle East and Africa (MEA) region is experiencing steady growth in the cardiovascular surgery devices and equipment market, accounting for around 10% of the global market share. Increasing healthcare investments, a rising awareness of cardiovascular diseases, and improving healthcare infrastructure are major factors contributing to the growth in this region. Saudi Arabia and the UAE are key markets within the MEA region.

Latin America

Latin America holds a smaller portion of the global market, with an estimated share of 5%. However, the region is expected to witness growth due to the increasing healthcare expenditure, improving healthcare facilities, and growing awareness about cardiovascular diseases. Brazil and Mexico are the leading markets for cardiovascular surgery devices in this region.

Cardiovascular Surgery Devices And Equipment Market Trends

This report provides an in depth analysis of various factors that impact the dynamics of Cardiovascular Surgery Devices And Equipment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Comprehensive Market Impact Matrix

This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.

Market Forces ↓ / Impact Areas →	Market Growth Rate	Competitive Landscape	Customer Behavior	Regulatory Influence	Innovation Potential
Drivers	High impact (e.g., tech adoption, rising demand)	Encourages new entrants and fosters expansion	Increases usage and enhances demand elasticity	Often aligns with progressive policy trends	Fuels R&D initiatives and product development
Restraints	Slows growth (e.g., high costs, supply chain issues)	Raises entry barriers and may drive market consolidation	Deters consumption due to friction or low awareness	Introduces compliance hurdles and regulatory risks	Limits innovation appetite and risk tolerance
Opportunities	Unlocks new segments or untapped geographies	Creates white space for innovation and M&A	Opens new use cases and shifts consumer preferences	Policy shifts may offer strategic advantages	Sparks disruptive innovation and strategic alliances

Drivers, Restraints and Opportunity Analysis

Drivers:

Rising prevalence of cardiovascular diseases.
Aging population worldwide.
Technological advancements in medical devices.
Increasing healthcare expenditure - Rising healthcare expenditure globally is a key driver of the cardiovascular surgery devices and equipment market, enabling greater access to advanced surgical interventions and life-saving technologies. As governments and private sectors allocate more funding to improve healthcare infrastructure, there is a significant uptick in the adoption of minimally invasive surgical tools, robotic-assisted systems, and next-generation cardiac devices. This increase in investment is especially impactful in both developed and emerging markets, where aging populations and the prevalence of cardiovascular diseases are accelerating demand for sophisticated treatment options.

Higher expenditure also facilitates broader availability of diagnostic facilities, specialized surgical centers, and trained personnel, all of which contribute to the rising volume of cardiovascular procedures. Insurance coverage expansion and public health initiatives further encourage patients to seek timely surgical care, leading to growing procurement of cardiopulmonary bypass systems, valve repair devices, and vascular grafts. As a result, increased healthcare spending directly enhances the adoption and technological advancement of cardiovascular surgery equipment, positioning it as a critical factor in market growth.

Restraints:

Stringent regulatory requirements.
High cost associated with advanced devices.
Reimbursement challenges in certain regions.
Limited access to healthcare in developing countries - Limited access to healthcare in developing countries remains a major restraint for the cardiovascular surgery devices and equipment market. Many low- and middle-income regions face challenges such as inadequate healthcare infrastructure, shortage of skilled medical professionals, and insufficient funding for advanced surgical technologies. These limitations reduce the availability of cardiovascular surgical procedures and delay timely diagnosis and treatment, ultimately restricting the demand for specialized equipment like heart-lung machines, valve repair tools, and minimally invasive surgical systems.

Affordability is another critical barrier, as patients in underserved regions often lack insurance coverage or the financial means to undergo costly surgical interventions. Public hospitals in these areas may operate with outdated or limited equipment, further impeding the adoption of advanced cardiovascular devices. Unless supported by targeted government initiatives, foreign aid, or strategic partnerships with private healthcare providers, these structural disparities will continue to hinder market expansion in emerging economies.

Opportunities:

Focus on preventive cardiology and early intervention.
Collaborations for research and development.
Integration of artificial intelligence and robotics.
Development of cost-effective solutions - The development of cost-effective solutions presents a promising opportunity for the cardiovascular surgery devices and equipment market, especially in regions with budget-constrained healthcare systems. With the growing burden of cardiovascular diseases in emerging markets, there is a pressing need for affordable surgical tools and devices that can deliver effective outcomes without significantly increasing healthcare costs. Manufacturers are responding by investing in low-cost innovations, modular systems, and simplified surgical technologies that are easier to deploy in resource-limited settings.

These efforts include the creation of disposable surgical kits, economical valve replacement devices, and portable cardiopulmonary support systems, all of which help reduce procedural costs while maintaining quality care standards. By addressing the cost barrier, such innovations can expand access to life-saving cardiovascular surgeries in underserved populations and rural healthcare networks. This market shift is also supported by public health programs and non-profit organizations that aim to scale affordable care through donations or subsidized procurement.

The integration of telemedicine and remote surgical training platforms further supports the dissemination of cost-effective cardiovascular surgery solutions. Surgeons and medical staff in low-resource settings can benefit from real-time guidance and training, helping ensure safe and efficient use of new technologies. These scalable models enhance not only the reach of surgical services but also the long-term adoption of economically viable equipment.

Cardiovascular Surgery Devices And Equipment Market Competitive Landscape Analysis

Key players in Cardiovascular Surgery Devices And Equipment Market include:

Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
Edwards Lifesciences Corporation
Terumo Corporation
Getinge AB
LivaNova PLC
B. Braun Melsungen AG
Johnson & Johnson
Baxter International Inc.

In this report, the profile of each market player provides following information:

Company Overview and Product Portfolio
Market Share Analysis
Key Developments
Financial Overview
Strategies
Company SWOT Analysis

Introduction
1. Research Objectives and Assumptions
2. Research Methodology
3. Abbreviations
Market Definition & Study Scope
Executive Summary
1. Market Snapshot, By Product
2. Market Snapshot, By Application
3. Market Snapshot, By End Use
4. Market Snapshot, By Region
Cardiovascular Surgery Devices And Equipment Market Dynamics
1. Drivers, Restraints and Opportunities
  1. Drivers
    1. Rising prevalence of cardiovascular diseases.
    2. Aging population worldwide.
    3. Technological advancements in medical devices.
    4. Increasing healthcare expenditure
  2. Restraints
    1. Stringent regulatory requirements.
    2. High cost associated with advanced devices.
    3. Reimbursement challenges in certain regions.
    4. Limited access to healthcare in developing countries.
  3. Opportunities
    1. Focus on preventive cardiology and early intervention.
    2. Collaborations for research and development.
    3. Integration of artificial intelligence and robotics.
    4. Development of cost-effective solutions.
  4. PEST Analysis
    1. Political Analysis
    2. Economic Analysis
    3. Social Analysis
    4. Technological Analysis
  5. Porter's Analysis
    1. Bargaining Power of Suppliers
    2. Bargaining Power of Buyers
    3. Threat of Substitutes
    4. Threat of New Entrants
    5. Competitive Rivalry
Market Segmentation
1. Cardiovascular Surgery Devices And Equipment Market, By Product, 2021 - 2031 (USD Million)
  1. Beating heart surgery systems
  2. Cardiopulmonary Bypass Equipment
  3. Cardiac Ablation Devices
  4. Perfusion Disposables
2. Cardiovascular Surgery Devices And Equipment Market, By Application, 2021 - 2031 (USD Million)
  1. Congenital Heart Defects
  2. Cardiac Arrhythmia
  3. Coronary Heart Disease
  4. Congestive Heart Failure
  5. Other Applications
3. Cardiovascular Surgery Devices And Equipment Market, By End Use, 2021 - 2031 (USD Million)
  1. Home and Ambulatory care
  2. Hospitals
  3. Diagnostic laboratories
  4. Research laboratories
4. Cardiovascular Surgery Devices And Equipment Market, By Geography, 2021 - 2031 (USD Million)
  1. North AmericaI
    1. Umited States
    2. Canada
  2. Europe
    1. Germany
    2. United Kingdom
    3. France
    4. Italy
    5. Spain
    6. Nordic
    7. Benelux
    8. Rest of Europe
  3. Asia Pacific
    1. Japan
    2. China
    3. India
    4. Australia & New Zealand
    5. South Korea
    6. ASEAN (Association of South East Asian Countries)
    7. Rest of Asia Pacific
  4. Middle East & Africa
    1. GCC
    2. Israel
    3. South Africa
    4. Rest of Middle East & Africa
  5. Latin America
    1. Brazil
    2. Mexico
    3. Argentina
    4. Rest of Latin America
Competitive Landscape
1. Company Profiles
  1. Medtronic plc
  2. Abbott Laboratories
  3. Boston Scientific Corporation
  4. Edwards Lifesciences Corporation
  5. Terumo Corporation
  6. Getinge AB
  7. LivaNova PLC
  8. B. Braun Melsungen AG
  9. Johnson & Johnson
  10. Baxter International Inc.
Analyst Views
Future Outlook of the Market